|
1
|
Mortality GBD: Global, regional, and
national age-sex specific all-cause and cause-specific mortality
for 240 causes of death, 1990–2013: A systematic analysis for the
Global Burden of Disease Study 2013. Lancet. 385:117–171. 2015.
View Article : Google Scholar
|
|
2
|
Henderson NC and Iredale JP: Liver
fibrosis: Cellular mechanisms of progression and resolution. Clin
Sci (Lond). 112:265–280. 2007. View Article : Google Scholar
|
|
3
|
Parsons CJ, Takashima M and Rippe RA:
Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol
Hepatol. 22(Suppl 1): S79–S84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsukada S, Parsons CJ and Rippe RA:
Mechanisms of liver fibrosis. Clin Chim Acta. 364:33–60. 2006.
View Article : Google Scholar
|
|
5
|
Cui W, Jin HB and Li ZW: Mechanism of the
transforming growth factor-beta induction of fibronectin expression
in hepatic stem-like cells. Braz J Med Biol Res. 43:36–42. 2010.
View Article : Google Scholar
|
|
6
|
Yoshida K, Murata M, Yamaguchi T and
Matsuzaki K: TGF-β/Smad signaling during hepatic
fibro-carcinogenesis (Review). Int J Oncol. 45:1363–1371.
2014.PubMed/NCBI
|
|
7
|
Kaimori A, Potter J, Kaimori JY, Wang C,
Mezey E and Koteish A: Transforming growth factor-beta1 induces an
epithelial-to-mesenchymal transition state in mouse hepatocytes in
vitro. J Biol Chem. 282:22089–22101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tahashi Y, Matsuzaki K, Date M, Yoshida K,
Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y and Inoue
K: Differential regulation of TGF-beta signal in hepatic stellate
cells between acute and chronic rat liver injury. Hepatology.
35:49–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wells RG: Cellular sources of
extracellular matrix in hepatic fibrosis. Clin Liver Dis.
12:759–768. viii2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Q and Jin S: The modern clinical
application and experimental research progress of turtule shell
pills. J Hebei Tradit Chin Med Pharmacol. 21:35–36. 2006.
|
|
11
|
Lin W, Wei N, Gao B, Jiang G and Chang Y:
Systematic evaluation of therapeutic effect of compound turtule
shell pills against hepatic fibrosis. Chin J Gastroenterol Hepatol.
16:69–72. 2007.
|
|
12
|
Gao J, Tao J and Zhao C: The experimental
study of turtle shell pills in prevention and treatment of hepatic
fibrosis. Chin Arch Tradit Chin Med. 11:2462–2471. 2008.
|
|
13
|
Xi Z, Luan X and Li K: The study of
dormant insect on inhibiting immune hepatic fibrosis in rats.
Tradit Chin Med Res. 17:38–40. 2001.
|
|
14
|
Xu L and Liu P: The observation of effects
on anti-hepatic fibrosis of peach extract-the study of
immunohistochemistry and collagen metabollism. Tradit Chin Med Res.
5:14–16. 1993.
|
|
15
|
Lu Y, Ren X and Chen Y: Dynamic
observation of the effects of turtle shell pills on liver collgen
and serum pre-collagen III during the hepatic fibrosis process in
rats. Henan Tradit Chin Med. 21:192001.
|
|
16
|
Moldovan GL, Pfander B and Jentsch S:
PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gressner AM, Weiskirchen R, Breitkopf K
and Dooley S: Roles of TGF-beta in hepatic fibrosis. Front Biosci.
7:d793–d807. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai H, Zhang WX, He XL, Zhao RX, Fang L
and Li CC: Effect of TGF-B1/Smad3 aignal pathway on airway
remodelling in asthma rats with the regulation of Radix Astragali.
Chin Arch Tradit Chin Med. 28:2494–2498. 2010.
|
|
19
|
Huang J, Zhang C, Zhan F and Zhang J:
Effects of astragalan on liver fibrosis rat in TGF-β1/Smads signal
pathway. China J Tradit Chin Med Pharm. 30:2184–2186. 2015.
|
|
20
|
Jiang W, Zhou ZS, Hu HB and Liu BJ: The
Effect of Fuling, Yiyiren and Dongguazi on serum TGF-β1 and TNF-α
levels in rats with pulmonary fibrosis. Med J Qilu. 28:237–240.
2013.
|
|
21
|
Niu SL, Wu ZL and Yao JJ: Hepatoprotective
effect of Artemisia capillaris thumb flavones extract on chronic
liver in-jury induced by carbon tetrachloride in rats. Med J Chin
People's Armed Police Forces. 26:162–166. 2015.
|
|
22
|
Shang LZ, Wang F, Wang Q, et al: Effects
and mechanism of chaihu shugan powder on TGF-β1/Smad signaling
pathways in hepatic fibrosis model rats. Chin J Exp Tradit Med
Formulae. 21:125–128. 2015.
|
|
23
|
Gao JR, Yao HP, Liu YW, et al: Turtle
carapace decoction and drug containing serum on hepatic stellate
cells. Chin Arch Tradit Chin Med. 31:2524–2528. 2013.
|
|
24
|
Zechini B, Pasquazzi C and Aceti A:
Correlation of serum aminotransferases with HCV RNA levels and
histological findings in patients with chronic hepatitis C: The
role of serum aspartate transaminase in the evaluation of disease
progression. Eur J Gastroenterol Hepatol. 16:891–896. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pradat P, Alberti A, Poynard T, Esteban
JI, Weiland O, Marcellin P, Badalamenti S and Trépo C: Predictive
value of ALT levels for histologic findings in chronic hepatitis C:
A European collaborative study. Hepatology. 36:973–977. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Natsume M, Tsuji H, Harada A, Akiyama M,
Yano T, Ishikura H, Nakanishi I, Matsushima K, Kaneko S and Mukaida
N: Attenuated liver fibrosis and depressed serum albumin levels in
carbon tetrachloride-treated IL-6-deficient mice. J Leukoc Biol.
66:601–608. 1999.PubMed/NCBI
|
|
27
|
Hassan EM, El-Kherbawy GM, Ali MAM and
Dewidar OM: The potential effect of special formulas on cirrhotic
rats. Food Nutr Sci. 4:594–603. 2013. View Article : Google Scholar
|
|
28
|
Soon RK Jr and Yee HF Jr: Stellate cell
contraction: Role, regulation, and potential therapeutic target.
Clin Liver Dis. 12:791–803. viii2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marra F: Hepatic stellate cells and the
regulation of liver inflammation. J Hepatol. 31:1120–1130. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanzler S, Baumann M, Schirmacher P, Dries
V, Bayer E, Gerken G, Dienes HP and Lohse AW: Prediction of
progressive liver fibrosis in hepatitis C infection by serum and
tissue levels of transforming growth factor-beta. J Viral Hepat.
8:430–437. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Date M, Matsuzaki K, Matsushita M, Tahashi
Y, Furukawa F and Inoue K: Modulation of transforming growth factor
beta function in hepatocytes and hepatic stellate cells in rat
liver injury. Gut. 46:719–724. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Flanders KC: Smad3 as a mediator of the
fibrotic response. Int J Exp Pathol. 85:47–64. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Latella G, Vetuschi A, Sferra R, Catitti
V, D'Angelo A, Zanninelli G, Flanders KC and Gaudio E: Targeted
disruption of Smad3 confers resistance to the development of
dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int.
29:997–1009. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dooley S, Hamzavi J, Breitkopf K,
Wiercinska E, Said HM, Lorenzen J, Ten Dijke P and Gressner AM:
Smad7 prevents activation of hepatic stellate cells and liver
fibrosis in rats. Gastroenterology. 125:178–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu MY, He YJ, Lv X, Liu ZH, Shen Y, Ye GR,
Deng YM and Shu JC: Transforming growth factor-β1 reduces apoptosis
via autophagy activation in hepatic stellate cells. Mol Med Rep.
10:1282–1288. 2014.PubMed/NCBI
|
